# Effect of Pyridorin in Patients With Diabetic Nephropathy

> **NCT00320021** · PHASE2 · COMPLETED · sponsor: **BioStratum** · enrollment: 80 (—)

## Conditions studied

- Diabetic Nephropathy

## Interventions

- **DRUG:** Pyridorin (pyridoxamine dihydrochloride)

## Key facts

- **NCT ID:** NCT00320021
- **Lead sponsor:** BioStratum
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** —
- **Final completion:** 2003-09
- **Target enrollment:** 80 (—)
- **Last updated:** 2006-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00320021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00320021, "Effect of Pyridorin in Patients With Diabetic Nephropathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00320021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*